Insmed, Inc. (INSM)
99.08
+4.91
(+5.21%)
USD |
NASDAQ |
Jun 09, 16:00
99.02
-0.06
(-0.06%)
After-Hours: 20:00
Insmed Research and Development Expense (Quarterly) : 209.48M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 108.31M |
| United Therapeutics Corp. | 138.20M |
| PTC Therapeutics, Inc. | 100.87M |
| Protagonist Therapeutics, Inc. | 46.74M |
| Alnylam Pharmaceuticals, Inc. | 364.87M |